AMENDTM Mitral Valve Repair System, Annuloplasty Ring Applied in a Transcatheter Method Read more about AMENDTM Mitral Valve Repair System, Annuloplasty Ring Applied in a Transcatheter Method
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Read more about Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Abbott Cephea Mitral Valve Disease Registry Read more about Abbott Cephea Mitral Valve Disease Registry
Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices Read more about Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II Read more about Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction Read more about A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA Read more about Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release Read more about Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation Read more about Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation